SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-104659
Filing Date
2021-04-02
Accepted
2021-04-02 08:10:29
Documents
3
Period of Report
2021-04-01
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d159237d8k.htm 8-K 21803
2 EX-99.1 d159237dex991.htm EX-99.1 10964
3 GRAPHIC g159237g43e29.jpg GRAPHIC 12485
  Complete submission text file 0001193125-21-104659.txt   45846
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39344 | Film No.: 21800538
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences